Project Grant HT94252310383
Award Date
9/1/23
Completion Date
8/31/27
Dollars Obligated
$750K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
The University of Washington was awarded a $1,312,384 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from August 1, 2022 to July 31, 2025 to target FZD6 sensitization of advanced prostate cancer to genotoxic stress. Through this funding, researchers at the University of Washington aim to investigate medical solutions for prostate cancer by exploring how targeting...
The U.S. Defense Health Agency awarded a $1,965,204 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Washington to support the early-stage development of an anti-inflammatory melanocortin fusion protein for tactical combat casualty care. The award period runs from August 1, 2024 to July 31, 2027. This research aims to investigate new therapeutic approaches for improving health outcomes for military service members. As a prominent...
The University of Washington was awarded a $1,810,550 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 through September 30, 2026 to investigate early chemodenervation of the detrusor muscle to preserve bladder compliance and function over the long term following spinal cord injury. The Military Medical Research and Development program supports basic,...
The University of Washington received a $617,221 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant funds research to advance the efficacy, longevity, and safety of gene editing therapies for Duchenne muscular dystrophy (DMD). The 2-year grant period runs from August 15, 2023 to August 14, 2025. As a leading research institution, the University of Washington has previously received federal funding to support a...
The federal Project Grant award of $932,918 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research at the University of Washington to determine the role of somatic mosaicism in ovarian cancer predisposition. The grant, awarded on September 30, 2024 with an ultimate completion date of September 29, 2028, will enable the University of Washington to conduct innovative scientific studies to improve health outcomes for military...
The University of Washington received a $622,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the fibrolamellar carcinoma tumor microenvironment using human tumor slice cultures. The award has a performance period from July 1, 2024 to June 30, 2026. Through this funding, the University of Washington will investigate innovative approaches to improve understanding of the fibrolamellar carcinoma tumor...
The University of Washington received a three-year, $708,603 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research into Differential ADAR1 Dependency in Breast Cancer, which aims to reveal therapeutic opportunities through regulation of MDM2 and ferropotosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and...
The Washington State University will receive $1,377,000 from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on the novel role and therapeutic targeting of LMO4 in lethal prostate cancer from July 1, 2023 to June 30, 2026. Through this three-year Project Grant, WSU researchers will investigate medical solutions for the battlefield by exploring the oncogenic functions of LMO4 and developing targeted therapies to...
The University of Washington was awarded a $1,166,250 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award will support long-read DNA sequencing and targeted RNA sequencing to identify previously undetectable classes of mutations in families with lethal prostate cancer. Through innovative biomedical research techniques, the project aims to transform healthcare for service...
The University of Washington was awarded a $1,137,371 project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from January 2021 through January 2025 to rapidly test a novel therapeutic strategy for COVID-19 using human organoids and blood vessel structures. The Military Medical Research and Development program aims to transform health care for service members and the public...